Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

226 Views

Poster Session: COVID-19: Treatment

1128 - Efficacy and Safety of Nelfinavir in Asymptomatic and Mild COVID-19 Patients: A Multicenter, Randomized Controlled Trial

Friday, October 21, 2022

12:15 PM – 1:30 PM US ET

Location: Hall B + C

The ePoster content is available to users who are logged in.<br><br>Please click the login button at the top right corner and then come back here to use this button.

Presenting Author(s)

SK

Shigeru Kohno, n/a

President
Nagasaki University
Nagasaki, Nagasaki, Japan

Co-Author(s)

TM

Taiga Miyazaki, n/a

University of Miyazaki
Miyazaki, Miyazaki, Japan
NH

Naoki Hosogaya, n/a

Nagasaki University
Nagasaki, Nagasaki, Japan
SM

Shinpei Morimoto, n/a

Nagasaki University
Nagasaki, Nagasaki, Japan
HY

Hiroshi Yamamoto, n/a

Nagasaki University
Nagasaki, Nagasaki, Japan
SI

Shingo Iwami, n/a

Nagoya University
Nagoya, Aichi, Japan
YM

Yoshitsugu Miyazaki, n/a

Director
National Institute of Infectious Diseases
Shinjuku-ku, Tokyo, Japan
HH

Hideki Hanaoka, n/a

Chiba University
Chiba, Chiba, Japan